Earnings Feed
Start Free
Home/Insiders/POTTS JOHN T JR
PJ
SEC Insider//CIK 0001202447

POTTS JOHN T JR

CIK 00012024473 companiesLINCOLNSHIRE, IL
SEC Profile

Transactions

31

Companies

3

Filings

8

CIK

0001202447

Recent Transactions

31 trades
  • Award
    ImmunityBio, Inc.$IBRX

    Common Stock

    2017-06-09+23,753→ 159,253 total
  • Gift
    ImmunityBio, Inc.$IBRX

    Common Stock

    2016-08-03−100,000→ 135,500 total
  • Exercise/Conversion
    ImmunityBio, Inc.$IBRX

    Stock Option (right to buy)

    2016-08-02−135,500→ 134,800 total
  • Exercise/Conversion
    ImmunityBio, Inc.$IBRX

    Common Stock

    2016-08-02$0.22/sh+135,500→ 235,500 total
  • Exercise/Conversion
    ImmunityBio, Inc.$IBRX

    Common Stock

    2016-02-10$0.22/sh+100,000→ 100,000 total
  • Exercise/Conversion
    ImmunityBio, Inc.$IBRX

    Stock Option (right to buy)

    2016-02-10−100,000→ 270,300 total
  • Award
    ANI PHARMACEUTICALS INC$ANIP

    Non-Statutory Stock Option (right to buy)

    2012-03-30+25,000→ 25,000 total
  • Award
    ANI PHARMACEUTICALS INC$ANIP

    Non-Statutory Stock Option (right to buy)

    2011-03-31+25,000→ 25,000 total
  • Award
    ANI PHARMACEUTICALS INC$ANIP

    Non-Statutory Stock Option (right to buy)

    2010-03-31+10,000→ 10,000 total
  • Disposition to Issuer
    CELL GENESYS INC

    Stock Option (right to buy)

    2009-10-14−7,500→ 0 total
  • Disposition to Issuer
    CELL GENESYS INC

    Stock Option (right to buy)

    2009-10-14−2,500→ 0 total
  • Disposition to Issuer
    CELL GENESYS INC

    Stock Option (right to buy)

    2009-10-14−7,500→ 0 total
  • Disposition to Issuer
    CELL GENESYS INC

    Stock Option (right to buy)

    2009-10-14−7,500→ 0 total
  • Disposition to Issuer
    CELL GENESYS INC

    Stock Option (right to buy)

    2009-10-14−7,500→ 0 total
  • Award
    ANI PHARMACEUTICALS INC$ANIP

    Common Stock

    2009-10-14+5,581→ 5,581 total
  • Award
    ANI PHARMACEUTICALS INC$ANIP

    Stock Option (right to buy)

    2009-10-14+15,000→ 15,000 total
  • Disposition to Issuer
    CELL GENESYS INC

    Stock Option (right to buy)

    2009-10-14−2,500→ 0 total
  • Disposition to Issuer
    CELL GENESYS INC

    Stock Option (right to buy)

    2009-10-14−7,500→ 0 total
  • Disposition to Issuer
    CELL GENESYS INC

    Stock Option (right to buy)

    2009-10-14−2,500→ 0 total
  • Disposition to Issuer
    CELL GENESYS INC

    Stock Option (right to buy)

    2009-10-14−2,500→ 0 total
  • Disposition to Issuer
    CELL GENESYS INC

    Stock Option (right to buy)

    2009-10-14−2,500→ 0 total
  • Disposition to Issuer
    CELL GENESYS INC

    Stock Option (right to buy)

    2009-10-14−2,500→ 0 total
  • Disposition to Issuer
    CELL GENESYS INC

    Stock Option (right to buy)

    2009-10-14−7,500→ 0 total
  • Disposition to Issuer
    CELL GENESYS INC

    Stock Option (right to buy)

    2009-10-14−7,500→ 0 total
  • Disposition to Issuer
    CELL GENESYS INC

    Stock Option (right to buy)

    2009-10-14−2,500→ 0 total
  • Disposition to Issuer
    CELL GENESYS INC

    Common Stock

    2009-10-14−30,536→ 0 total
  • Disposition to Issuer
    CELL GENESYS INC

    Stock Option (right to buy)

    2009-10-14−7,500→ 0 total
  • Award
    CELL GENESYS INC

    Stock Option (Right to Buy)

    2007-06-29+7,500→ 7,500 total
  • Award
    CELL GENESYS INC

    Common Stock

    2007-06-29+4,000→ 10,536 total
  • Award
    CELL GENESYS INC

    Stock Option (Right to Buy)

    2006-06-30$5.02/sh+7,500→ 7,500 total
  • Award
    CELL GENESYS INC

    Stock Option (right to buy)

    2005-06-30$5.35/sh+7,500→ 87,500 total

Companies

3

Recent Filings

8

Address

C/O BIOSANTE PHARMACEUTICALS, INC. 111 BARCLAY BOULEVARD, SUITE 280

LINCOLNSHIRE, IL, 60069

View on SEC.gov